VAL.L

ValiRx plc VAL.L

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VAL.L PYC.L GDR.L TRLS.L ROQ.L TCF.L CRTX.L FUM.L CIZ.L FDBK.L
6M 5.00 % 7.59 % -59.73 % -51.47 % 2.70 % -6.67 % 15.79 % -76.56 % 3.33 % -41.53 %
YTD -30.00 % -43.33 % -75.51 % 57.14 % -54.76 % -60.00 % 4.76 % -93.06 % -3.13 % -44.80 %
1Y -75.58 % -37.04 % -75.51 % 22.22 % -50.65 % -68.42 % 29.41 % -93.45 % -27.91 % -80.29 %
3Y -96.56 % -80.23 % -94.00 % -93.13 % -75.48 % -95.28 % -95.70 % -94.50 % -3.13 % -89.38 %
5Y -98.09 % -93.61 % -99.36 % -98.84 % -71.85 % -98.50 % -97.02 % -84.70 % -83.47 % -94.83 %
10Y -99.98 % -92.27 % -99.54 % -98.84 % -71.85 % -99.39 % -99.99 % -91.57 % -83.47 % -98.10 %
From the beginning -100.00 % -99.80 % -99.50 % -98.84 % -71.85 % -99.39 % -100.00 % -96.93 % -83.47 % -99.93 %

Dividend

CRISM Therapeutics Corporation

Feedback plc